Quetiapine for schizophrenia
59 results
1 - 59Quetiapine for schizophrenia
Quetiapine versus other atypical antipsychotics for schizophrenia
Quetiapine versus typical antipsychotic medications for schizophrenia: Cochrane systematic review
Clozapine combined with different antipsychotic drugs for treatment‐resistant schizophrenia
Risperidone versus other atypical antipsychotics for schizophrenia
Clozapine versus other atypical antipsychotics for schizophrenia
Olanzapine versus other atypical antipsychotics for schizophrenia
Ziprasidone versus other atypical antipsychotics for schizophrenia
Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
Switching antipsychotics versus continued current treatment in people with non‐responsive schizophrenia
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia
Molindone for schizophrenia and severe mental illness: Cochrane systematic review
Chlorpromazine versus atypical antipsychotic drugs for schizophrenia
Atypical antipsychotics for people with both schizophrenia and depression
Oral paliperidone for schizophrenia: Cochrane systematic review
Aripiprazole versus other atypical antipsychotics for schizophrenia: Cochrane systematic review
Risperidone (depot) for schizophrenia
Amisulpride versus other atypical antipsychotics for schizophrenia
Antipsychotic drug treatment for elderly people with late‐onset schizophrenia
Lurasidone versus typical antipsychotics for schizophrenia
Loxapine for schizophrenia
Sertindole versus other atypical antipsychotics for schizophrenia
Bifeprunox versus placebo for schizophrenia
Zotepine versus other atypical antipsychotics for schizophrenia
Amisulpride for schizophrenia
New generation antipsychotics for first episode schizophrenia
Risperidone versus other antipsychotics for people with severe mental illness and co‐occurring substance misuse
Risperidone for psychosis‐induced aggression or agitation (rapid tranquillisation)
Newer atypical antipsychotic medication versus clozapine for schizophrenia: Cochrane systematic review
Management of sexual dysfunction due to antipsychotic drug therapy
Increasing antipsychotic dose for non response in schizophrenia
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
Haloperidol dose for the acute phase of schizophrenia
Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia